- Home
- About
- Team
- Today's Market
- Premium
- Research it
- Outlook
- Portfolio
- Mobile
- Trust Equitymaster
- Help
- Free Reports
MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- RUPA & COMPANY LIMITED (textiles)
- Latest 8 Quarter Result
RUPA & CO. Quarterly Results 
(RUPA)
Here are the latest quarterly results of RUPA & CO.. For more details, see the RUPA & CO. financial fact sheet and RUPA & CO. share price and chart.
RUPA & CO. Quarterly Results
| No. of Mths Qtr. Ending |
3
Jun-16 |
3
Sep-16 |
3
Dec-16 |
3
Mar-17 |
3
Jun-17 |
3
Sep-17 |
3
Dec-17 |
3
Mar-18 |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 2,203 | 2,724 | 2,096 | 3,818 | 1,635 | 2,482 | 2,780 | 4,203 | |
| Other income | Rs m | 9 | 12 | 5 | 9 | 11 | 12 | 7 | 4 | |
| Turnover | Rs m | 2,212 | 2,736 | 2,101 | 3,827 | 1,645 | 2,495 | 2,787 | 4,207 | |
| Expenses | Rs m | 1,908 | 2,346 | 1,763 | 3,415 | 1,446 | 2,099 | 2,366 | 3,527 | |
| Gross profit | Rs m | 295 | 379 | 333 | 403 | 189 | 383 | 413 | 675 | |
| Depreciation | Rs m | 37 | 38 | 38 | 38 | 39 | 37 | 35 | 33 | |
| Interest | Rs m | 31 | 26 | 31 | 17 | 18 | 21 | 21 | 16 | |
| Profit before tax | Rs m | 236 | 326 | 268 | 357 | 142 | 338 | 364 | 630 | |
| Tax | Rs m | 83 | 114 | 98 | 122 | 50 | 121 | 126 | 231 | |
| Profit after tax | Rs m | 154 | 212 | 170 | 235 | 93 | 216 | 238 | 399 | |
| Gross profit margin | % | 13.4 | 13.9 | 15.9 | 10.6 | 11.5 | 15.4 | 14.9 | 16.1 | |
| Effective tax rate | % | 35.0 | 35.0 | 36.7 | 34.2 | 34.8 | 36.0 | 34.6 | 36.7 | |
| Net profit margin | % | 7.0 | 7.8 | 8.1 | 6.2 | 5.7 | 8.7 | 8.6 | 9.5 | |
| Diluted EPS | Rs | 1.9 | 2.7 | 2.1 | 3.0 | 1.2 | 2.7 | 3.0 | 5.0 | |
| Diluted EPS (TTM) | Rs | 9.8 | 8.8 | 9.2 | 9.7 | 8.9 | 9.0 | 9.8 | 11.9 | |
 Subscriber Feature |
||||||||||
Interim results exclude extraordinary / exceptional items
Read: RUPA & CO. 4QFY18 Result Performance Review
More Textiles Company Quarterly Results: AVANTI FEEDS LINC PEN & PLASTICS LTD FORTIS HEALTHCARE REDINGTON (INDIA) KARUTURI GLOBAL
Compare RUPA & CO. With: AVANTI FEEDS LINC PEN & PLASTICS LTD FORTIS HEALTHCARE REDINGTON (INDIA) KARUTURI GLOBAL
Compare RUPA & CO. With: IBM (US) KINGDEE INTER. (China) HP (US) CHINASOFT (China)
|
| |
Today's Market
Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)
Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.
Views on news
RUPA & CO. Announces Quarterly Results (4QFY18); Net Profit Up 69.6% (Quarterly Result Update)
May 31, 2018 | Updated on May 31, 2018For the quarter ended March 2018, RUPA & CO. has posted a net profit of Rs 399 m (up 69.6% YoY). Sales on the other hand came in at Rs 4 bn (up 10.1% YoY). Read on for a complete analysis of RUPA & CO.'s quarterly results.
Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)
Mar 14, 2018Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?
Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)
Mar 12, 2018Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?
Apollo Micro Systems Ltd. (IPO)
Jan 9, 2018Should you subscribe to the IPO of Apollo Micro Systems Ltd?
Khadim India Ltd. (IPO)
Oct 31, 2017Should you subscribe to the IPO of Khadim India Ltd?
More Views on NewsMost Popular
How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)
Jul 12, 2018Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.
The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)
Jul 10, 2018If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...
The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)
Jul 11, 2018The price signals that MSP sends out, creates its own set of problems.
New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)
Jul 6, 2018ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.
When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)
Jul 6, 2018Buy Companies that can fight all kinds of Pandas and Bears in the long run.
More|
| |
RUPA & CO. SHARE PRICE
Jul 18, 2018 (Close)
TRACK RUPA & CO.
- Track your investment in RUPA & CO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON RUPA & CO.
RUPA & CO. 5-YR ANALYSIS
COMPARE RUPA & CO. WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.